LightPath Technologies, Inc.
LightPath Technologies, Inc. sells visible precision optical components, infrared components including molded and diamond-turned aspheric lenses, assemblies, modules and cameras to customers in defense, medical devices, laser industrial tools, automotive safety, barcode scanning, optical data storage, telecommunications and machine vision via direct sales and distributors by designing, developing, manufacturing and distributing precision optics. LightPath Technologies, Inc. sells engineering services to customers via direct sales and distributors by providing engineering services.
LOCKED
Market: NormalKey Catalysts & Risks
The most important medium-term driver is the U.S. defense push to eliminate reliance on optical glass and optical systems sourced from certain foreign nations, a rule whose final deadline sits late in the decade but which is forcing sourcing decisions now because optical qualification cycles run two to three years; this is mainly an upside catalyst that could convert into multi-year orders for LightPath's BlackDiamond materials and camera systems. Execution on converting the record backlog into revenue and expanding melting, coating and assembly capacity in the U.S. and Latvia is the second key variable and is ambiguous, since success would validate the vertical-integration thesis and support margin expansion while delays or cost overruns on the higher capital spending planned for fiscal 2027 would pressure near-term cash and returns. A third catalyst is the redesign of the acquired G5 cooled camera family onto BlackDiamond, which management describes as progressing technically but behind schedule; completing it would remove germanium exposure and strengthen the long-range camera offering, while further slippage would delay that benefit. Progress on named defense programs such as the Lockheed Martin interceptor effort, counter-UAS and border-surveillance work is a swing factor in both directions, since the Army has already extended one program timeline and some government funding has not yet converted into camera orders. Management has also signalled an active M&A pipeline funded from the strengthened balance sheet, which could add capability but carries integration and further dilution risk.
LightPath's revenue is increasingly concentrated in a small number of defense customers and programs, and its filings disclose that customer concentration has risen with a single customer representing a substantial share of revenue, so the loss of or a delay in a major program could materially affect results and is a structural feature of the defense-supplier model rather than a cyclical swing. Its earnings are also structurally exposed to government budget and procurement timing the company does not control, which has already produced program-timeline extensions and funding that has not translated into orders, making revenue recognition lumpy. Reported results have been volatile because of non-cash remeasurement of acquisition earnout liabilities tied to the G5 deal, which management notes will keep flowing through operating expenses until settled, complicating the earnings picture even as adjusted profitability improves. The strategy has been funded in part by repeated equity and preferred issuances, so ongoing dilution and the influence of the preferred investor holding a board seat are persistent considerations for minority shareholders over the next 12 to 36 months.
Research refreshed: 3rd of October 2026
KPIs and Peer Benchmarks
| EV | P/E | Net Debt/EBIT | Revenue Growth | |
|---|---|---|---|---|
| Coherent, I… (COHR) | 68.3B | 77.48 | 2.79 | 22.5% |
| MKS Inc. (MKSI) | 22.4B | 42.68 | 4.99 | 9.6% |
| Teledyne Te… (TDY) | 30.3B | 29.71 | 1.36 | 7.9% |
| LightPath T… (LPTH) | -93.2T | N.M. | N.M. | 92.8% |
AI Opinion
Fundamentals
Demand is materially stronger than the older macro report suggests: FY2026 revenue grew 93%, June backlog reached $110.9 million, and $24 million of July production orders are scheduled for FY2027 delivery. The earnings call establishes a credible systems-led recovery, but $85.6 million of backlog requested within 12 months is not revenue guidance. Glass capacity, detector availability and concentrated defense programs determine conversion into shareholder value.
Peer Comparison
No reliable peer valuation or profitability ranking is available for COHR, MKSI or TDY. LPTH's proprietary materials and defense qualifications support differentiation but do not establish superior capital efficiency or justify a peer premium.
Macro Environment
Defense sourcing restrictions and germanium substitution directly support BlackDiamond demand, with qualification cycles bringing purchasing decisions forward into the next 12 months despite a later regulatory deadline. Government procurement delays and detector lead times of ten months or more can defer revenue. Favorable technology sentiment is secondary context; the 5.24% Treasury yield increases valuation sensitivity. Older European exposure estimates are insufficient to establish current regional demand after the business transformation.
Key Metrics
Market capitalization of $693.2 million implies approximately 9.7x FY2026 revenue; subtracting cash and adding stated debt implies approximately 8.4x enterprise value/revenue before lease and preferred adjustments. This is demanding for a cash-consuming business without quantitative FY2027 guidance. Gross margin of 35.98% and Q4 adjusted EBITDA margin near 10% support recovery, while FCF margin of -23% and ROIC of -0.69% constrain conviction. The supplied -1.64% operating-margin ratio conflicts with the detailed $19.65 million operating loss and is not relied upon.
Insider Activity
Historical sales of approximately $90.07 million versus $1,746 purchased provide bearish secondary context, moderated by associated derivative conversions. No transactions occurred during the latest 90 days, so insider activity supplies no fresh catalyst or reliable current valuation signal.
Income Statement
FY2026 revenue was $71.7 million, gross margin approximately 36%, and adjusted EBITDA $4.2 million versus a $5.1 million prior-year loss. Q4 revenue reached $21.2 million, gross margin 39.4%, and adjusted EBITDA $2.1 million. The call identifies mix, yields and absorption improvements and explains $15.6 million of annual noncash earn-out remeasurement, materially qualifying the reported operating-loss deterioration; nevertheless, Q4 GAAP net loss remained $4.1 million. Prior-year inventory reserves also inflated the Q4 margin comparison.
Cash Flow
FY2026 operating cash flow was negative $10.23 million and FCF negative $16.49 million, including $9.65 million of working-capital cash use and $6.3 million of CapEx. Higher FY2027 CapEx and advance detector purchases may prolong cash burn despite positive adjusted EBITDA. Recovery requires backlog deliveries to generate collections, gross-profit growth to exceed recurring expense growth, and operating cash flow to improve during FY2027; cash-flow normalization is not yet established.
Balance Sheet
Cash of $93.2 million, effectively no stated debt and $26.18 million of current liabilities provide substantial capacity-expansion funding. Liquidity came primarily from equity financing rather than operations; diluted weighted-average shares increased 30.6%, and acquisitions and preferred securities remain dilution risks. Lease obligations total $10.74 million.